About the Speaker
Zameel Cader Is Scientific Director of IMI StemBANCC and is the Director of the Oxford Headache Centre. He is also Clinical Director for Mental Health, Dementia and Neurology for the Strategic Clinical Network. He is Associate Professor in Clinical Neurosciences at the Nuffield Department of Clinical Neuroscience and the Weatherall Institute of Molecular Medicine. His research programme is focused on understanding the disease process in neurodysfunctional disorders such as migraine and neurodegenerative disorders such as Alzheimer's Disease using cell biology, model organism and human imaging studies. His group is now working with MRC Technology to bring more effective treatments arising from these findings to clinic.
AbstractThis presentation will focus on stemBANCC and its progress in developing disease relevant models as well as how we hope to turn these into drug screening assays.
Disease Modelling and Drug Discovery in Neurological Disorders
Video Apr 29, 2016
CryostaX® hepatocytes are created using a patented process that produces unique single-donor cell pellets. This format allows for distinct benefits to hepatocyte performance, efficiency in the lab, and test system design, precipitating the potential discontinuation of cryopreserved hepatocytes prepared from traditional methods. This webinar will discuss the technology, its optimal utilization and benefitsWATCH NOW